TuHURA Biosciences, Inc./NV SEC filings HURA

TuHURA Biosciences, Inc./NV has 928 filings in SEC EDGAR's recent list, going back to Aug 17, 2010. Its latest annual report, Form ARS, was filed on Jul 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (new debt). The company's fiscal year ends on December 31.

TuHURA Biosciences, Inc./NV SEC filings
Form Description Filed Period
8-K Current report
New debt
Oct 16, 2026 Oct 9, 2026
8-K Current report
New debt
Sep 24, 2026 Sep 21, 2026
8-K Current report
New debt
Sep 17, 2026 Sep 14, 2026
8-K/A Amended current report
Officer or director change
Sep 17, 2026 Sep 10, 2026
8-K Current report
Officer or director change
Sep 16, 2026 Sep 10, 2026
8-K Current report
New debt
Sep 4, 2026 Sep 2, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 28, 2026 —
8-K Current report
New debt
Aug 21, 2026 Aug 20, 2026
8-K Current report
Unregistered share sale, Shareholder vote results
Aug 19, 2026 Aug 18, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
8-K Current report
New debt
Aug 13, 2026 Aug 7, 2026
8-K Current report
New debt
Jul 29, 2026 Jul 28, 2026
ARS Annual report to shareholders Jul 9, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jul 9, 2026 —
DEF 14A Proxy statement Jul 9, 2026 Aug 18, 2026
8-K Current report
New debt
Jul 7, 2026 Jun 30, 2026
PRE 14A Preliminary proxy statement Jun 26, 2026 Aug 18, 2026
8-K Current report Jun 17, 2026 Jun 17, 2026
8-K Current report
New debt
May 29, 2026 May 26, 2026
4 Insider transaction May 29, 2026 May 28, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2026 May 15, 2026
8-K/A Amended current report
Other events
Apr 30, 2026 Apr 2, 2026
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Apr 22, 2026 Apr 21, 2026
424B5 Prospectus supplement Apr 8, 2026 —
8-K Current report
Officer or director change, Other events
Apr 8, 2026 Apr 2, 2026
8-K Current report
Results of operations
Apr 1, 2026 Apr 1, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
8-K Current report
Listing notice
Jan 30, 2026 Jan 29, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Dec 17, 2025 Dec 12, 2025
4 Insider transaction Dec 17, 2025 Dec 12, 2025
8-K Current report
Material agreement, Other events
Dec 10, 2025 Dec 9, 2025
424B5 Prospectus supplement Dec 10, 2025 —
8-K Current report
Material agreement, New debt
Dec 5, 2025 Dec 2, 2025
8-K Current report
Regulation FD disclosure
Nov 25, 2025 Nov 25, 2025
424B3 Prospectus Nov 25, 2025 —
8-K Current report
Other events
Nov 18, 2025 Nov 18, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
D Filing Nov 10, 2025 —
8-K Current report
Material agreement
Nov 4, 2025 Nov 3, 2025
S-3 Shelf registration Nov 3, 2025 —
8-K Current report
Other events
Nov 3, 2025 Nov 3, 2025
424B3 Prospectus Oct 31, 2025 —
8-K Current report
Material agreement, New debt
Oct 31, 2025 Oct 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 31, 2025 —
EFFECT Filing Sep 26, 2025 —
424B3 Prospectus Sep 26, 2025 —
UPLOAD Letter from the SEC Sep 25, 2025 —
CORRESP Letter to the SEC Sep 24, 2025 —
CORRESP Letter to the SEC Sep 18, 2025 —
S-1/A Amended registration statement Sep 18, 2025 —
8-K Current report
Material agreement
Sep 11, 2025 Sep 5, 2025
UPLOAD Letter from the SEC Aug 28, 2025 —
CORRESP Letter to the SEC Aug 25, 2025 —
UPLOAD Letter from the SEC Aug 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
S-1 Registration statement Aug 12, 2025 —
8-K/A Amended current report Aug 12, 2025 Jun 30, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 29, 2025 —
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Jun 30, 2025 Jun 30, 2025
8-K Current report
Bylaw or fiscal year change
Jun 27, 2025 Jun 23, 2025
425 Filing Jun 24, 2025 —
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jun 24, 2025 Jun 23, 2025
D Filing Jun 13, 2025 —
8-K Current report Jun 12, 2025 Jun 6, 2025
425 Filing Jun 6, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jun 6, 2025 Jun 2, 2025
425 Filing Jun 3, 2025 —
ARS Annual report to shareholders May 23, 2025 Dec 31, 2024
424B3 Prospectus May 23, 2025 —
10-Q Quarterly report May 15, 2025 Mar 31, 2025
425 Filing May 15, 2025 —
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
EFFECT Filing May 14, 2025 —
425 Filing May 13, 2025 —
CORRESP Letter to the SEC May 12, 2025 —
S-4/A Filing May 8, 2025 —
8-K/A Amended current report
Officer or director change
May 7, 2025 Mar 7, 2025
425 Filing May 7, 2025 —
8-K Current report
Material agreement, Officer or director change
May 7, 2025 May 5, 2025
CORRESP Letter to the SEC May 6, 2025 —
S-4/A Filing May 6, 2025 —
425 Filing May 5, 2025 —
425 Filing Apr 28, 2025 —
425 Filing Apr 8, 2025 —
425 Filing Apr 1, 2025 —
8-K Current report
Results of operations
Apr 1, 2025 Apr 1, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
4 Insider transaction Mar 19, 2025 Mar 10, 2025
3 Initial insider ownership Mar 19, 2025 Mar 10, 2025
8-K Current report
Regulation FD disclosure
Mar 18, 2025 Mar 18, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 12, 2025 Mar 7, 2025
UPLOAD Letter from the SEC Feb 20, 2025 —
8-K Current report
Material agreement
Feb 14, 2025 Feb 12, 2025
S-4 Registration for a merger or exchange Feb 7, 2025 —
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
8-K Current report
Auditor change
Jan 3, 2025 Dec 27, 2024
S-8 Employee stock plan registration Dec 23, 2024 —
425 Filing Dec 12, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Dec 12, 2024 Dec 11, 2024
8-K Current report
Regulation FD disclosure
Nov 25, 2024 Nov 25, 2024
8-K Current report
Officer or director change
Nov 15, 2024 Nov 15, 2024
8-K/A Amended current report
Acquisition or sale of assets
Nov 14, 2024 Oct 18, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
4 Insider transaction Nov 14, 2024 Nov 12, 2024
4 Insider transaction Nov 14, 2024 Nov 12, 2024
SC 13G Ownership over 5% (passive) Oct 25, 2024 —
SC 13G Ownership over 5% (passive) Oct 25, 2024 —
SC 13G Ownership over 5% (passive) Oct 25, 2024 —
SC 13G Ownership over 5% (passive) Oct 25, 2024 —
SC 13D Ownership over 5% (active) Oct 25, 2024 —
SC 13D Ownership over 5% (active) Oct 25, 2024 —
4 Insider transaction Oct 22, 2024 Oct 18, 2024
3 Initial insider ownership Oct 22, 2024 Oct 18, 2024
4 Insider transaction Oct 22, 2024 Oct 18, 2024
3 Initial insider ownership Oct 22, 2024 Oct 18, 2024
4 Insider transaction Oct 22, 2024 Oct 18, 2024
3 Initial insider ownership Oct 22, 2024 Oct 18, 2024
4 Insider transaction Oct 22, 2024 Oct 18, 2024
3 Initial insider ownership Oct 22, 2024 Oct 18, 2024
3 Initial insider ownership Oct 22, 2024 Oct 18, 2024
4 Insider transaction Oct 22, 2024 Oct 18, 2024
3 Initial insider ownership Oct 22, 2024 Oct 18, 2024
4 Insider transaction Oct 22, 2024 Oct 18, 2024
3 Initial insider ownership Oct 22, 2024 Oct 18, 2024
8-K Current report
Material agreement, Acquisition or sale of assets, Results of operations, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
Oct 21, 2024 Oct 18, 2024
EFFECT Filing Oct 15, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Oct 15, 2024 Oct 15, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 15, 2024 Oct 14, 2024
POS AM Filing Oct 8, 2024 —
8-K Current report
Other events
Oct 8, 2024 Oct 8, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Oct 8, 2024 Oct 8, 2024
10-K Annual report Oct 7, 2024 Jun 30, 2024
425 Filing Oct 4, 2024 —
8-K Current report
Shareholder vote results
Oct 4, 2024 Oct 4, 2024
NT 10-K Filing Sep 30, 2024 Jun 30, 2024
424B3 Prospectus Sep 25, 2024 —
425 Filing Sep 25, 2024 —
8-K Current report
Material agreement
Sep 25, 2024 Sep 25, 2024
425 Filing Sep 24, 2024 —
8-K Current report
Regulation FD disclosure
Sep 24, 2024 Sep 24, 2024
425 Filing Sep 20, 2024 —
8-K Current report
Shareholder vote results, Regulation FD disclosure
Sep 20, 2024 Sep 20, 2024
425 Filing Sep 19, 2024 —
8-K Current report
Regulation FD disclosure
Sep 19, 2024 Sep 18, 2024
425 Filing Sep 18, 2024 —
8-K Current report
Regulation FD disclosure
Sep 18, 2024 Sep 18, 2024
425 Filing Sep 11, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Sep 11, 2024 Sep 11, 2024
425 Filing Sep 9, 2024 —
8-K Current report
Regulation FD disclosure
Sep 9, 2024 Sep 9, 2024
425 Filing Sep 3, 2024 —
8-K Current report
Regulation FD disclosure
Sep 3, 2024 Sep 3, 2024
425 Filing Aug 19, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Aug 19, 2024 Aug 19, 2024
424B3 Prospectus Aug 19, 2024 —
SEC STAFF LETTER Filing Aug 13, 2024 —
EFFECT Filing Aug 13, 2024 —
CORRESP Letter to the SEC Aug 12, 2024 —
S-4/A Filing Aug 12, 2024 —
CORRESP Letter to the SEC Aug 8, 2024 —
S-4/A Filing Aug 8, 2024 —
UPLOAD Letter from the SEC Aug 1, 2024 —
CORRESP Letter to the SEC Jul 19, 2024 —
S-4/A Filing Jul 19, 2024 —
8-K Current report
Bylaw or fiscal year change
Jul 12, 2024 Jul 12, 2024
UPLOAD Letter from the SEC Jul 10, 2024 —
425 Filing Jul 8, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jul 8, 2024 Jul 3, 2024
425 Filing Jul 1, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jul 1, 2024 Jul 1, 2024
CORRESP Letter to the SEC Jun 27, 2024 —
S-4/A Filing Jun 27, 2024 —
8-K Current report
Shareholder vote results
Jun 24, 2024 Jun 20, 2024
425 Filing Jun 13, 2024 —
8-K Current report
Listing notice
Jun 13, 2024 Jun 12, 2024
SEC STAFF LETTER Filing Jun 10, 2024 —
UPLOAD Letter from the SEC Jun 7, 2024 —
425 Filing Jun 3, 2024 —
8-K Current report
Regulation FD disclosure
Jun 3, 2024 Jun 3, 2024
ARS Annual report to shareholders May 17, 2024 Jun 30, 2023
DEF 14A Proxy statement May 17, 2024 Jun 20, 2024
425 Filing May 14, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HURA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Tampa, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1498382
Former names
Kintara Therapeutics, Inc. (until Oct 22, 2024); DelMar Pharmaceuticals, Inc. (until Aug 18, 2020); Berry Only Inc. (until Jan 18, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.